Allergan, Inc. v. Merz Pharms., LLC

Full title: ALLERGAN, INC., a Delaware Corporation, Plaintiff, v. MERZ…

Court: UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA - WESTERN DIVISION

Date published: May 14, 2013

Case No. SACV 11-446 AG (Ex) (C.D. Cal. May. 14, 2013)

Opinion

Case No. SACV 11-446 AG (Ex)

05-14-2013

ALLERGAN, INC., a Delaware Corporation, Plaintiff, v. MERZ PHARMACEUTICALS, LLC, a North Carolina corporation, et al., Defendant. MERZ PHARMACEUTICALS, LLC, a North Carolina Corporation, Counterclaimants, v. ALLERGAN, INC., a Delaware corporation, Counterdefendant.

Andrew J. Guilford

Assigned for all purposes to

Honorable Andrew J. Guilford

FINAL JUDGMENT PURSUANT

TO FED. R. CIV. PROC. 58

FINAL JUDGMENT

Pursuant to Federal Rule of Civil Procedure 58, final judgment shall be entered in this action pursuant to this Court's Orders entered on February 1, 2012 (Dkt. No. 207), March 9, 2012 (Dkt. No. 286), May 7, 2012 (Dkt. Nos. 322 and 324), October 1, 2012 (Dkt. No. 368), and October 10, 2012 (Dkt. No. 371), and in light of the fact that Merz Pharmaceuticals, LLC and Merz Aesthetics, Inc. have filed their Second Status Report Regarding Corporate Compliance Program on March 8, 2013 (Dkt. No. 436). All parties shall bear their own fees and costs.

IT SO ORDERED.

_________________________

Hon. Andrew J. Guilford

United States District Judge